is semaglutide off the fda shortage list GLP-1 Drugs: Removes from Drug FDA: Novo Nordisk's Ozempic and

Benefits Direct activation of the IGF-1 receptor for anabolic signaling: IGF-1 LR3 binds directly to the IGF-1 receptor expressed on muscle and other peripheral tissues

Once-weekly GLP2 versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): A randomised, open-label, parallel-group, phase 3 trial

Carnitine is transferred across the placenta, primarily during the third trimester, so preterm infants often develop carnitine deficiencies

Novel Small Molecule GLP-1R Agonists

In 2025, 36% of employers offered to cover GLP-1 drugs as a treatment for both obesity and diabetes, with about 55% covering diabetes alone